Gliclazide API

Holiness Pharmaceutical is a trusted and leading manufacturer and Pharmaceutical API exporter of Gliclazide API in IP, BP, EP, and USP grades, supplying high-quality and regulatory-compliant anti-diabetic APIs to pharmaceutical companies across 40+ countries. With strong expertise in oral hypoglycemic agents, we are recognized as one of the most reliable Gliclazide bulk API suppliers from India for immediate-release and modified-release formulations used in type 2 diabetes management.

Worldwide, Holiness Pharmaceutical is regarded among the most reputable Gliclazide API manufacturers, known for delivering excellent purity, uniform particle characteristics, robust stability, and complete regulatory documentation. Our specialization in diabetic-care APIs makes us a preferred partner for companies seeking a dependable Pharmaceutical API exporter for metabolic and endocrine formulations.

Our advanced anti-diabetic API manufacturing facilities operate under strict compliance with major international pharmaceutical regulations such as:
➡ DCGI, WHO-GMP, US-FDA aligned, and cGMP standards,
ensuring validated production systems, rigorous impurity control, consistent assay values, and globally accepted pharmacopeial quality for Gliclazide API.

We export premium-grade Gliclazide and other metabolic APIs from India to Asia, Africa, the Middle East, Europe, North America, South America, and CIS regions, supporting formulation manufacturers producing essential diabetes therapies. Holiness Pharmaceutical is widely trusted as a bulk Gliclazide API supplier for large-scale commercial production.

Holiness Pharmaceutical is one of the industry's leading producers of APIs (Active Pharmaceutical Ingredients) and Intermediates, delivering strong reliability, regulatory-compliant manufacturing, and globally recognized product quality as a certified Pharmaceutical API exporter specializing in anti-diabetic APIs.

Holiness Pharmaceutical Ltd is a fully integrated pharmaceutical organization involved in the complete lifecycle of API development — including R&D innovation, anti-diabetic API processing, commercial-scale manufacturing, HPAPI capabilities, and worldwide distribution of APIs and intermediates.

Recognized globally as a dependable API partner, Holiness Pharmaceutical is positioned among the top API manufacturers in India, supported by advanced production technology, strong analytical capability, and a rapidly expanding international distribution network as a leading bulk API supplier.

Holiness Pharmaceutical has established a significant presence in many countries including:
United States, Canada, United Kingdom, Germany, France, Netherlands, Italy, Spain, Australia, New Zealand, Slovakia, Estonia, Belarus, Ukraine, Iceland, Kazakhstan, Uzbekistan, Turkmenistan, Tajikistan, Kyrgyzstan, Georgia, Russia, Yemen, Saudi Arabia, UAE, Qatar, Kuwait, Oman, Bahrain, Turkey, Senegal, Ethiopia, Eswatini, Cameroon, Zambia, Mozambique, Angola, Zimbabwe, Malawi, Seychelles, South Africa, Nigeria, Kenya, Tanzania, Ghana, Egypt, Panama, Costa Rica, El Salvador, Mexico, Brazil, Argentina, Chile, Peru, Colombia, Afghanistan, Bhutan, Cambodia, Vietnam, Indonesia, Philippines, Malaysia, Thailand, South Korea, Japan, Paraguay, Bangladesh.